Helicobacter pylori Biofilm-Related Drug Resistance and New Developments in Its Anti-Biofilm Agents

References

• Warren JR, Marshall B. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1(8336):1273–1275.
   PubMed Web of Science ®Google Scholar
• Zamani M, Ebrahimtabar F, Zamani V, et al. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection. Aliment Pharmacol Ther. 2018;47(7):868–876. doi:10.1111/apt.14561
   PubMed Web of Science ®Google Scholar
• Malfertheiner P, Megraud F, O’Morain CA, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence consensus report. Gut. 2017;66(1):6–30. doi:10.1136/gutjnl-2016-312288
   PubMed Web of Science ®Google Scholar
• Rather MA, Gupta K, Mandal M. Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies. Braz J Microbiol. 2021;52(4):1701–1718. doi:10.1007/s42770-021-00624-x
   PubMed Web of Science ®Google Scholar
• Yonezawa H, Osaki T, Hojo F, Kamiya S. Effect of Helicobacter pylori biofilm formation on susceptibility to amoxicillin, metronidazole and clarithromycin. Microb Pathog. 2019;132:100–108. doi:10.1016/j.micpath.2019.04.030
   PubMed Web of Science ®Google Scholar
• Chen L, Wen YM. The role of bacterial biofilm in persistent infections and control strategies. Int J Oral Sci. 2011;3(2):66–73. doi:10.4248/IJOS11022
   PubMed Web of Science ®Google Scholar
• Yonezawa H, Osaki T, Kamiya S. Biofilm formation by helicobacter pylori and its involvement for antibiotic resistance. Biomed Res Int. 2015;2015:914791. doi:10.1155/2015/914791
   PubMed Web of Science ®Google Scholar
• Eick S. Biofilms. Monogr Oral Sci. 2021;29:1–11. doi:10.1159/000510184
   Google Scholar
• Flemming HC, Wuertz S. Bacteria and archaea on Earth and their abundance in biofilms. Nat Rev Microbiol. 2019;17(4):247–260. doi:10.1038/s41579-019-0158-9
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol. 2004;2(2):95–108. doi:10.1038/nrmicro821
   PubMed Web of Science ®Google Scholar
• Attaran B, Falsafi T, Moghaddam AN. Study of biofilm formation in C57Bl/6J mice by clinical isolates of Helicobacter pylori. Saudi J Gastroenterol. 2016;22(2):161–168. doi:10.4103/1319-3767.178529
   Web of Science ®Google Scholar
• Jia J, Zhang C, Liu Y, et al. Armeniaspirol A: a novel anti-Helicobacter pylori agent. Microb Biotechnol. 2021;15(2):442–454. doi:10.1111/1751-7915.13807
   Web of Science ®Google Scholar
• Yonezawa H, Osaki T, Kurata S, Zaman C, Hanawa T, Kamiya S. Assessment of in vitro biofilm formation by Helicobacter pylori. J Gastroenterol Hepatol. 2010;25 Suppl 1:S90–S94. doi:10.1111/j.1440-1746.2009.06213.x
   Web of Science ®Google Scholar
• Chandki R, Banthia P, Banthia R. Biofilms: a microbial home. J Indian Soc Periodontol. 2011;15(2):111–114. doi:10.4103/0972-124X.84377
   Google Scholar
• Kolenbrander PE, Palmer RJ, Periasamy S, Jakubovics NS. Oral multispecies biofilm development and the key role of cell-cell distance. Nat Rev Microbiol. 2010;8(7):471–480. doi:10.1038/nrmicro2381
   PubMed Web of Science ®Google Scholar
• Fuqua WC, Winans SC, Greenberg EP. Quorum sensing in bacteria: the LuxR-LuxI family of cell density-responsive transcriptional regulators. J Bacteriol. 1994;176(2):269–275. doi:10.1128/jb.176.2.269-275.1994
   PubMed Web of Science ®Google Scholar
• Hall MR, Mcgillicuddy E, Kaplan LJ. Biofilm: basic principles, pathophysiology, and implications for clinicians. Surg Infect (Larchmt). 2014;15(1):1–7. doi:10.1089/sur.2012.129
   PubMed Web of Science ®Google Scholar
• Solano C, Echeverz M, Lasa I. Biofilm dispersion and quorum sensing. Curr Opin Microbiol. 2014;18:96–104. doi:10.1016/j.mib.2014.02.008
   PubMed Web of Science ®Google Scholar
• Vinod KK, Lall C, Vimal RR, Vedhagiri K, Sunish IP, Vijayachari P. Can subminimal inhibitory concentrations of antibiotics induce the formation of biofilm in leptospira? Microb Drug Resist. 2018;24(7):1040–1042. doi:10.1089/mdr.2017.0409
   Web of Science ®Google Scholar
• Ng WL, Bassler BL. Bacterial quorum-sensing network architectures. Annu Rev Genet. 2009;43(1):197–222. doi:10.1146/annurev-genet-102108-134304
   PubMed Web of Science ®Google Scholar
• Muhammad MH, Idris AL, Fan X, et al. Beyond risk: bacterial biofilms and their regulating approaches. Front Microbiol. 2020;11:928. doi:10.3389/fmicb.2020.00928
   PubMed Web of Science ®Google Scholar
• Kalia VC. Quorum sensing inhibitors: an overview. Biotechnol Adv. 2013;31(2):224–245. doi:10.1016/j.biotechadv.2012.10.004
   PubMed Web of Science ®Google Scholar
• Zhou L, Yu Y, Chen X, et al. The multiple DSF-family QS signals are synthesized from carbohydrate and branched-chain amino acids via the FAS elongation cycle. Sci Rep. 2015;5(1):13294. doi:10.1038/srep13294
   Web of Science ®Google Scholar
• Cole SP, Harwood J, Lee R, She R, Guiney DG. Characterization of monospecies biofilm formation by Helicobacter pylori. J Bacteriol. 2004;186(10):3124–3132. doi:10.1128/JB.186.10.3124-3132.2004
   PubMed Web of Science ®Google Scholar
• Wong EH, Ng CG, Chua EG, et al. Comparative genomics revealed multiple helicobacter pylori genes associated with biofilm formation in vitro. PLoS One. 2016;11(11):e166835. doi:10.1371/journal.pone.0166835
   PubMed Web of Science ®Google Scholar
• Yonezawa H, Osaki T, Fukutomi T, et al. Diversification of the AlpB outer membrane protein of helicobacter pylori affects biofilm formation and cellular adhesion. J Bacteriol. 2017;199(6). doi:10.1128/JB.00729-16
   Web of Science ®Google Scholar
• Servetas SL, Doster RS, Kim A, et al. ArsRS-dependent regulation of homB contributes to Helicobacter pylori biofilm formation. Front Microbiol. 2018;9:1497. doi:10.3389/fmicb.2018.01497
   Web of Science ®Google Scholar
• Ge X, Cai Y, Chen Z, et al. Bifunctional enzyme SpoT is involved in biofilm formation of helicobacter pylori with multidrug resistance by upregulating efflux pump hp1174 (gluP). Antimicrob Agents Chemother. 2018;62(11). doi:10.1128/AAC.00957-18
   Web of Science ®Google Scholar
• Zhao Y, Cai Y, Chen Z, et al. SpoT-mediated NapA upregulation promotes oxidative stress-induced Helicobacter pylori biofilm formation and confers multidrug resistance. Antimicrob Agents Chemother. 2021;65(5). doi:10.1128/AAC.00152-21
   Web of Science ®Google Scholar
• Cai Y, Wang C, Chen Z, et al. Transporters HP0939, HP0497, and HP0471 participate in intrinsic multidrug resistance and biofilm formation in Helicobacter pylori by enhancing drug efflux. Helicobacter. 2020;25(4):e12715. doi:10.1111/hel.12715
   PubMed Web of Science ®Google Scholar
• Christensen GD, Simpson WA, Younger JJ, et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol. 1985;22(6):996–1006. doi:10.1128/jcm.22.6.996-1006.1985
   PubMed Web of Science ®Google Scholar
• Stepanovic S, Vukovic D, Dakic I, Savic B, Svabic-Vlahovic M. A modified microtiter-plate test for quantification of staphylococcal biofilm formation. J Microbiol Methods. 2000;40(2):175–179. doi:10.1016/S0167-7012(00)00122-6
   PubMed Web of Science ®Google Scholar
• Hassan A, Usman J, Kaleem F, Omair M, Khalid A, Iqbal M. Evaluation of different detection methods of biofilm formation in the clinical isolates. Braz J Infect Dis. 2011;15(4):305–311. doi:10.1016/S1413-8670(11)70197-0
   PubMed Web of Science ®Google Scholar
• Sanchez MC, Llama-Palacios A, Marin MJ, et al. Validation of ATP bioluminescence as a tool to assess antimicrobial effects of mouthrinses in an in vitro subgingival-biofilm model. Med Oral Patol Oral Cir Bucal. 2013;18(1):e86–e92. doi:10.4317/medoral.18376
   Web of Science ®Google Scholar
• Dhale RP, Ghorpade MV, Dharmadhikari CA. Comparison of various methods used to detect biofilm production of Candida species. J Clin Diagn Res. 2014;8(11):C18–C20. doi:10.7860/JCDR/2014/10445.5147
   Google Scholar
• Gomes F, Teixeira P, Cerca N, Azeredo J, Oliveira R. Effect of farnesol on structure and composition of Staphylococcus epidermidis biofilm matrix. Curr Microbiol. 2011;63(4):354–359. doi:10.1007/s00284-011-9984-3
   PubMed Web of Science ®Google Scholar
• Zufferey J, Rime B, Francioli P, Bille J. Simple method for rapid diagnosis of catheter-associated infection by direct acridine Orange staining of catheter tips. J Clin Microbiol. 1988;26(2):175–177. doi:10.1128/jcm.26.2.175-177.1988
   PubMed Web of Science ®Google Scholar
• Penesyan A, Paulsen IT, Gillings MR, Kjelleberg S, Manefield MJ. Secondary effects of antibiotics on microbial biofilms. Front Microbiol. 2020;11:2109. doi:10.3389/fmicb.2020.02109
   Web of Science ®Google Scholar
• Tseng BS, Zhang W, Harrison JJ, et al. The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin. Environ Microbiol. 2013;15(10):2865–2878. doi:10.1111/1462-2920.12155
   PubMed Web of Science ®Google Scholar
• Keren I, Kaldalu N, Spoering A, Wang Y, Lewis K. Persister cells and tolerance to antimicrobials. Fems Microbiol Lett. 2004;230(1):13–18. doi:10.1016/S0378-1097(03)00856-5
   PubMed Web of Science ®Google Scholar
• Krzyzek P, Gosciniak G. A proposed role for diffusible signal factors in the biofilm formation and morphological transformation of Helicobacter pylori. Turk J Gastroenterol. 2018;29(1):7–13. doi:10.5152/tjg.2017.17349
   Web of Science ®Google Scholar
• El ML, Tejada-Arranz A, Rifflet A, et al. A peptide of a type I toxin-antitoxin system induces Helicobacter pylori morphological transformation from spiral shape to coccoids. Proc Natl Acad Sci U S A. 2020;117(49):31398–31409. doi:10.1073/pnas.2016195117
   Web of Science ®Google Scholar
• Lewis K. Persister cells, dormancy and infectious disease. Nat Rev Microbiol. 2007;5(1):48–56. doi:10.1038/nrmicro1557
   PubMed Web of Science ®Google Scholar
• Zhang Y. Persisters, persistent infections and the Yin-Yang model. Emerg Microbes Infect. 2014;3(1):e3. doi:10.1038/emi.2014.3
   Web of Science ®Google Scholar
• Yonezawa H, Osaki T, Hanawa T, Kurata S, Ochiai K, Kamiya S. Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations. PLoS One. 2013;8(9):e73301. doi:10.1371/journal.pone.0073301
   PubMed Web of Science ®Google Scholar
• Bae J, Oh E, Jeon B. Enhanced transmission of antibiotic resistance in Campylobacter jejuni biofilms by natural transformation. Antimicrob Agents Chemother. 2014;58(12):7573–7575. doi:10.1128/AAC.04066-14
   PubMed Web of Science ®Google Scholar
• Madsen JS, Burmolle M, Hansen LH, Sorensen SJ. The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol Med Microbiol. 2012;65(2):183–195. doi:10.1111/j.1574-695X.2012.00960.x
   PubMedGoogle Scholar
• Merod RT, Wuertz S, Spormann AM. Extracellular polymeric substance architecture influences natural genetic transformation of Acinetobacter baylyi in biofilms. Appl Environ Microbiol. 2014;80(24):7752–7757. doi:10.1128/AEM.01984-14
   Web of Science ®Google Scholar
• Hathroubi S, Zerebinski J, Clarke A, Ottemann KM. Helicobacter pylori biofilm confers antibiotic tolerance in part via a protein-dependent mechanism. Antibiotics. 2020;9(6). doi:10.3390/antibiotics9060355
   Web of Science ®Google Scholar
• Okshevsky M, Meyer RL. The role of extracellular DNA in the establishment, maintenance and perpetuation of bacterial biofilms. Crit Rev Microbiol. 2015;41(3):341–352. doi:10.3109/1040841X.2013.841639
   PubMed Web of Science ®Google Scholar
• Ma JF, Hager PW, Howell ML, Phibbs PV, Hassett DJ. Cloning and characterization of the Pseudomonas aeruginosa zwf gene encoding glucose-6-phosphate dehydrogenase, an enzyme important in resistance to methyl viologen (paraquat). J Bacteriol. 1998;180(7):1741–1749. doi:10.1128/JB.180.7.1741-1749.1998
   Web of Science ®Google Scholar
• Clardy J, Fischbach MA, Currie CR. The natural history of antibiotics. Curr Biol. 2009;19(11):R437–R441. doi:10.1016/j.cub.2009.04.001
   Web of Science ®Google Scholar
• Melander RJ, Basak AK, Melander C. Natural products as inspiration for the development of bacterial antibiofilm agents. Nat Prod Rep. 2020;37(11):1454–1477. doi:10.1039/d0np00022a
   PubMed Web of Science ®Google Scholar
• Carradori S, Di Giacomo N, Lobefalo M, Luisi G, Campestre C, Sisto F. Biofilm and quorum sensing inhibitors: the road so far. Expert Opin Ther Pat. 2020;30(12):917–930. doi:10.1080/13543776.2020.1830059
   PubMed Web of Science ®Google Scholar
• Maccelli A, Carradori S, Puca V, et al. Correlation between the antimicrobial activity and metabolic profiles of cell free supernatants and membrane vesicles produced by lactobacillus reuteri DSM 17938. Microorganisms. 2020;8(11):1653. doi:10.3390/microorganisms8111653
   PubMed Web of Science ®Google Scholar
• Di Lodovico S, Napoli E, Di Campli E, et al. Pistacia vera L. Oleoresin and levofloxacin is a synergistic combination against resistant Helicobacter pylori strains. Sci Rep. 2019;9(1):4646. doi:10.1038/s41598-019-40991-y
   Web of Science ®Google Scholar
• Luo P, Huang Y, Hang X, et al. Dihydrotanshinone I is effective against drug-resistant Helicobacter pylori in vitro and in vivo. Antimicrob Agents Chemother. 2021;65(3). doi:10.1128/AAC.01921-20
   Web of Science ®Google Scholar
• Bai CL, Osaki T, Yonezawa H, et al. In vitro and in vivo effects of the Mongolian drug Amu-ru 7 on Helicobacter pylori growth and viability. Microbiol Immunol. 2010;54(9):508–515. doi:10.1111/j.1348-0421.2010.00246.x
   Web of Science ®Google Scholar
• Sposito L, Oda FB, Vieira JH, et al. In vitro and in vivo anti-Helicobacter pylori activity of Casearia sylvestris leaf derivatives. J Ethnopharmacol. 2019;233:1–12. doi:10.1016/j.jep.2018.12.032
   PubMed Web of Science ®Google Scholar
• Cataldi V, Di Bartolomeo S, Di Campli E, Nostro A, Cellini L, Di Giulio M. In vitro activity of Aloe vera inner gel against microorganisms grown in planktonic and sessile phases. Int J Immunopathol Pharmacol. 2015;28(4):595–602. doi:10.1177/0394632015600594
   Web of Science ®Google Scholar
• Graham DY. Efficient identification and evaluation of effective Helicobacter pylori therapies. Clin Gastroenterol Hepatol. 2009;7(2):145–148. doi:10.1016/j.cgh.2008.10.024
   PubMed Web of Science ®Google Scholar
• Megraud F, Lehours P. Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev. 2007;20(2):280–322. doi:10.1128/CMR.00033-06
   PubMed Web of Science ®Google Scholar
• Vagarali MA, Metgud SC, Bannur H, Karadesai SG, Nagmoti JM. Clinical significance of various diagnostic techniques and emerging antimicrobial resistance pattern of Helicobacter pylori from gastric biopsy samples. Indian J Med Microbiol. 2015;33(4):560–564. doi:10.4103/0255-0857.167349
   Web of Science ®Google Scholar
• Jin F, Yang H. Effects of Lactobacillus salivarius LN12 in Combination with amoxicillin and clarithromycin on Helicobacter pylori biofilm in vitro. Microorganisms. 2021;9(8):1611. doi:10.3390/microorganisms9081611
   Web of Science ®Google Scholar
• Krzyzek P, Migdal P, Paluch E, Karwanska M, Wieliczko A, Gosciniak G. Myricetin as an antivirulence compound interfering with a morphological transformation into coccoid forms and potentiating activity of antibiotics against Helicobacter pylori. Int J Mol Sci. 2021;22(5):2695. doi:10.3390/ijms22052695
   Web of Science ®Google Scholar
• Arif M, Sharaf M, Samreen KS, Chi Z, Liu CG. Chitosan-based nanoparticles as delivery-carrier for promising antimicrobial glycolipid biosurfactant to improve the eradication rate of Helicobacter pylori biofilm. J Biomater Sci Polym Ed. 2021;32(6):813–832. doi:10.1080/09205063.2020.1870323
   PubMed Web of Science ®Google Scholar
• Cai J, Huang H, Song W, et al. Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro. Int J Pharm. 2015;495(2):728–737. doi:10.1016/j.ijpharm.2015.09.055
   PubMed Web of Science ®Google Scholar
• Puca V, Traini T, Guarnieri S, et al. The antibiofilm effect of a medical device containing TIAB on microorganisms associated with surgical site infection. Molecules. 2019;24(12):2280. doi:10.3390/molecules24122280
   PubMed Web of Science ®Google Scholar
• Grande R, Sisto F, Puca V, et al. Antimicrobial and antibiofilm activities of new synthesized silver Ultra-NanoClusters (SUNCs) against helicobacter pylori. Front Microbiol. 2020;11:1705. doi:10.3389/fmicb.2020.01705
   PubMed Web of Science ®Google Scholar
• Shen Y, Zou Y, Chen X, et al. Antibacterial self-assembled nanodrugs composed of berberine derivatives and rhamnolipids against Helicobacter pylori. J Control Release. 2020;328:575–586. doi:10.1016/j.jconrel.2020.09.025
   PubMed Web of Science ®Google Scholar
• Cammarota G, Branca G, Ardito F, et al. Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial. Clin Gastroenterol Hepatol. 2010;8(9):817–820. doi:10.1016/j.cgh.2010.05.006
   Web of Science ®Google Scholar
• Zuin R, Palamidese A, Negrin R, Catozzo L, Scarda A, Balbinot M. High-dose N-acetylcysteine in patients with exacerbations of chronic obstructive pulmonary disease. Clin Drug Investig. 2005;25(6):401–408. doi:10.2165/00044011-200525060-00005
   PubMed Web of Science ®Google Scholar
• Marchese A, Bozzolasco M, Gualco L, Debbia EA, Schito GC, Schito AM. Effect of fosfomycin alone and in combination with N-acetylcysteine on E. Coli biofilms. Int J Antimicrob Agents. 2003;22 Suppl 2:95–100. doi:10.1016/s0924-8579(03)00232-2
   Web of Science ®Google Scholar
• Olofsson AC, Hermansson M, Elwing H. N-acetyl-L-cysteine affects growth, extracellular polysaccharide production, and bacterial biofilm formation on solid surfaces. Appl Environ Microbiol. 2003;69(8):4814–4822. doi:10.1128/AEM.69.8.4814-4822.2003
   PubMed Web of Science ®Google Scholar
• Perez-Giraldo C, Rodriguez-Benito A, Moran FJ, Hurtado C, Blanco MT, Gomez-Garcia AC. Influence of N-acetylcysteine on the formation of biofilm by Staphylococcus epidermidis. J Antimicrob Chemother. 1997;39(5):643–646. doi:10.1093/jac/39.5.643
   PubMed Web of Science ®Google Scholar
• Di Campli E, Di Bartolomeo S, Grande R, Di Giulio M, Cellini L. Effects of extremely low-frequency electromagnetic fields on Helicobacter pylori biofilm. Curr Microbiol. 2010;60(6):412–418. doi:10.1007/s00284-009-9558-9
   Web of Science ®Google Scholar
• Darmani H, Am SE, Mb BS. Blue light emitting diodes cripple Helicobacter pylori by targeting its virulence factors. Minerva Gastroenterol Dietol. 2019;65(3):187–192. doi:10.23736/S1121-421X.19.02593-5
   PubMed Web of Science ®Google Scholar
• Darmani H, Smadi E, Bataineh S. Blue light emitting diodes enhance the antivirulence effects of Curcumin against Helicobacter pylori. J Med Microbiol. 2020;69(4):617–624. doi:10.1099/jmm.0.001168
   PubMed Web of Science ®Google Scholar
• Lucio-Sauceda DG, Urrutia-Baca VH, Gomez-Flores R, De La Garza-ramos MA, Tamez-Guerra P, Orozco-Flores A. Antimicrobial and anti-biofilm effect of an electrolyzed superoxidized solution at neutral-pH against Helicobacter pylori. Biomed Res Int. 2019;2019:6154867. doi:10.1155/2019/6154867
   Google Scholar
• Stewart PS, Bjarnsholt T. Risk factors for chronic biofilm-related infection associated with implanted medical devices. Clin Microbiol Infect. 2020;26(8):1034–1038. doi:10.1016/j.cmi.2020.02.027
   PubMed Web of Science ®Google Scholar
• Thi M, Wibowo D, Rehm B. Pseudomonas aeruginosa Biofilms. Int J Mol Sci. 2020;21(22):8671. doi:10.3390/ijms21228671
   PubMed Web of Science ®Google Scholar
• Sharma G, Sharma S, Sharma P, et al. Escherichia coli biofilm: development and therapeutic strategies. J Appl Microbiol. 2016;121(2):309–319. doi:10.1111/jam.13078
   PubMed Web of Science ®Google Scholar
• Gedefie A, Demsis W, Ashagrie M, et al. Acinetobacter baumannii biofilm formation and its role in disease pathogenesis: a review. Infect Drug Resist. 2021;14:3711–3719. doi:10.2147/IDR.S332051
   PubMed Web of Science ®Google Scholar
• Otto M, Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI. Staphylococcal biofilms. Microbiol Spectr. 2018;6(4). doi:10.1128/microbiolspec.GPP3-0023-2018
   PubMedGoogle Scholar
• Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev. 2004;17(2):255–267. doi:10.1128/CMR.17.2.255-267.2004
   PubMed Web of Science ®Google Scholar
• Grande R, Di Marcantonio MC, Robuffo I, et al. Helicobacter pylori ATCC 43629/NCTC 11639 Outer Membrane Vesicles (OMVs) from biofilm and planktonic phase associated with extracellular DNA (eDNA). Front Microbiol. 2015;6:1369. doi:10.3389/fmicb.2015.01369
   PubMed Web of Science ®Google Scholar
• Fauzia KA, Miftahussurur M, Syam AF, et al. Biofilm formation and antibiotic resistance phenotype of helicobacter pylori clinical isolates. Toxins. 2020;12(8):473. doi:10.3390/toxins12080473
   PubMed Web of Science ®Google Scholar
• Krzyzek P, Junka A, Slupski W, et al. Antibiofilm and antimicrobial-enhancing activity of Chelidonium majus and Corydalis cheilanthifolia extracts against multidrug-resistant Helicobacter pylori. Pathogens. 2021;10(8):1033. doi:10.3390/pathogens10081033
   Web of Science ®Google Scholar
• Yu M, Wang X, Ling F, Wang H, Zhang P, Shao S. Atractylodes lancea volatile oils attenuated helicobacter pylori NCTC11637 growth and biofilm. Microb Pathog. 2019;135:103641. doi:10.1016/j.micpath.2019.103641
   Web of Science ®Google Scholar
• Vetvicka V, Vetvickova J, Fernandez-Botran R. Effects of curcumin on Helicobacter pylori infection. Ann Transl Med. 2016;4(24):479. doi:10.21037/atm.2016.12.52
   Web of Science ®Google Scholar
• Krzyzek P, Gosciniak G, Fijalkowski K, et al. Potential of bacterial cellulose chemisorbed with anti-metabolites, 3-bromopyruvate or sertraline, to fight against Helicobacter pylori lawn biofilm. Int J Mol Sci. 2020;21(24):9507. doi:10.3390/ijms21249507
   Web of Science ®Google Scholar
• Zhang L, Wu WK, Gallo RL, et al. Critical role of antimicrobial peptide cathelicidin for controlling helicobacter pylori survival and infection. J Immunol. 2016;196(4):1799–1809. doi:10.4049/jimmunol.1500021
   PubMed Web of Science ®Google Scholar
• Bugli F, Palmieri V, Torelli R, et al. In vitro effect of clarithromycin and alginate lyase against helicobacter pylori biofilm. Biotechnol Prog. 2016;32(6):1584–1591. doi:10.1002/btpr.2339
   Web of Science ®Google Scholar
• Tran TH, Truong THH, Nguyen TTL, Nguyen VMH, Thi NM, Luong TM. Growth-inhibiting, bactericidal, antibiofilm, and urease inhibitory activities of Hibiscus rosa sinensis L. flower constituents toward antibiotic sensitive- and resistant-strains of Helicobacter pylori. ACS Omega. 2020;5(32):20080–20089. doi:10.1021/acsomega.0c01640
   PubMed Web of Science ®Google Scholar
• Chen X, Li P, Shen Y, Zou Y, Yuan G, Hu H. Rhamnolipid-involved antibiotics combinations improve the eradication of Helicobacter pylori biofilm in vitro: a comparison with conventional triple therapy. Microb Pathog. 2019;131:112–119. doi:10.1016/j.micpath.2019.04.001
   PubMed Web of Science ®Google Scholar
• Shen Y, Li P, Chen X, et al. Activity of sodium lauryl sulfate, rhamnolipids, and N-Acetylcysteine against biofilms of five common pathogens. Microb Drug Resist. 2020;26(3):290–299. doi:10.1089/mdr.2018.0385
   Web of Science ®Google Scholar
• Di Fermo P, Di Lodovico S, Amoroso R, et al. Searching for new tools to counteract the helicobacter pylori resistance: the positive action of resveratrol derivatives. Antibiotics. 2020;9(12). doi:10.3390/antibiotics9120891
   Web of Science ®Google Scholar
• Ji J, Yang H. In vitro effects of lactobacillus plantarum ln66 and antibiotics used alone or in combination on Helicobacter pylori mature biofilm. Microorganisms. 2021;9(2):424. doi:10.3390/microorganisms9020424
   Web of Science ®Google Scholar
• Wylie MR, Windham IH, Blum FC, Wu H, Merrell DS. In vitro antibacterial activity of nimbolide against Helicobacter pylori. J Ethnopharmacol. 2022;285:114828. doi:10.1016/j.jep.2021.114828
   Web of Science ®Google Scholar
• Grande R, Carradori S, Puca V, et al. Selective inhibition of helicobacter pylori carbonic anhydrases by carvacrol and thymol could impair biofilm production and the release of outer membrane vesicles. Int J Mol Sci. 2021;22(21):11583. doi:10.3390/ijms222111583
   PubMed Web of Science ®Google Scholar
• Spiegel M, Krzyzek P, Dworniczek E, Adamski R, Sroka Z. In silico screening and in vitro assessment of natural products with anti-virulence activity against Helicobacter pylori. Molecules. 2021;27(1):20. doi:10.3390/molecules27010020
   Web of Science ®Google Scholar